.png)
Melanoma is a significant health concern, with incidence rates rising globally. In Australia, melanoma incidence is particularly high, and it's considered "Australia's national cancer". This lecture will cover the two most common treatments for melanoma in Australia: Immunotherapy and Surgery. Immunotherapy plays a central role in treating melanoma, from reducing recurrence risk after surgery to improving survival in advanced stages.
Melanoma surgery primarily involves wide local excision, removing the melanoma and a surrounding margin of healthy tissue to prevent recurrence. Sentinel lymph node biopsy may also be performed to check for spread to nearby lymph nodes. It is important for physiotherapists to be aware of the various treatment regimens and any modifications to treatment and exercises plans they may need to make for their patient on active melanoma treatment.
Francis Proulx-Rocray (Melanoma Medical Oncology Fellow, Melanoma Institute Australia) is a Medical Oncologist from Montreal, Canada. He completed his training with the University of Montreal in 06.2024. And had been a Melanoma fellow at MIA since 02.2025. He has particular interest in skin cancer and immunotherapy toxicities.
Shahn Coburn (Senior Clinical Nurse Consultant, Melanoma Institute Australia) is a surgical clinical nurse consultant at Melanoma Institute Australia. She has completed her masters in nursing oncology and is currently undergoing a master of Nurse Practitioner. She has interests in education and complex wound management
Cancer, Palliative Care and Lymphoedema National Group
24/09/2025
1.0 hour
Please note: The content of this Lecture on Demand (LOD) was captured via a recording of a live lecture at the APA premises. Due to the nature of the event and the recording method, this LOD may not have captured some of the questions/comments from live audience. Your purchase of this module indicates your acceptance of this.
.png)
.png)
